PAX7 and rhabdomyosarcoma: For example, MYCN in MYCN-amplified neuroblastoma and the PAX3–FOXO1 and PAX7–FOXO1 fusion proteins in alveolar rhabdomyosarcoma promote tumour growth by hijacking tumour-type-specific CRC TFs15–19.